logo
  

RedHill Biopharma Presents Positive Oral Opaganib Phase 2 Data In COVID-19

RedHill Biopharma Ltd. (RDHL) said that it has presented the positive phase 2 safety and efficacy data for oral opaganib or Yeliva, ABC294640 in hospitalized patients with COVID-19 pneumonia at the World Microbe Forum 2021.

Findings from the 40-patient U.S. Phase 2 study include 50% of patients treated with opaganib reached room air by Day 14 compared to 22% in the placebo group. The benefit of reaching room air by Day 14 for patients on opaganib was maintained regardless of whether the patients were receiving dexamethasone and/or remdesivir.

According to the study results, 86.4% of patients treated with opaganib were discharged from hospital by Day 14 compared to 55.6% of patients treated with placebo.

Median time to discharge was 6 days for the opaganib group compared to 7.5 days for the placebo group.

The company noted that 81.8% of opaganib patients achieved a 2-point improvement in the WHO Ordinal Scale compared to 55.6% of patients in the placebo group - achieved in a median time of 6 days versus 7.5 days, respectively.

The data, from this proof-of-concept clinical study of opaganib in patients with severe COVID-19, suggested a potential role of SK2 inhibition in combating the effects of this virus. With much more data on opaganib expected in the coming weeks, the company could make some real progress toward having access to a much-needed oral therapy for patients who currently have a paucity of options available to them, RedHill Biopharma said.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Velvet Ice Cream recalled certain lots of its 56 oz Raspberry Fudge Cordial Ice Cream for potentially containing undeclared peanuts, the U.S. Food and Drug Administration or FDA said in a statement. The recall was initiated after it was notified of the issue by a single customer and has since learned that the cause of the error has been traced to a third-party manufacturer packaging error. Willard, Ohio-based Buurma Farms Inc. is recalling 320 boxes of its Plain Parsley citing possible contamination with Shiga-toxin producing E.coli, the U.S. Food and Drug Administration said. The recall involves Buurma Plain (flat leaf) Parsley with a harvest date of August 30, 2021 from their Gregory, Michigan location. Molson Coors Beverage Co. is bringing Topo Chico Hard Seltzer, the sparkling mineral water, across the United States starting January 2022. The company will officially expand the distribution of the product, which was launched last spring in nine states and seven metro areas, to all 50 states. Molson Coors is manufacturing, marketing and distributing Topo Chico Hard Seltzer in the U.S.
Follow RTT